🇺🇸 FDA
Pipeline program

CS-101

CS-101-06

Phase 1 mab completed

Quick answer

CS-101 for Beta-Thalassemia is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Beta-Thalassemia
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials